ReShape Lifesciences Inc. (RSLS) Tops Q1 EPS by 1898c

ReShape Lifesciences Inc. (NASDAQ: RSLS) reported Q1 EPS of $18.98. Revenue for the quarter came in at $1.1 million.

For earnings history and earnings-related data on ReShape Lifesciences Inc. (RSLS) click here.

You May Also Be Interested In

• UBS says bull market has further to run
• PennyMac Mortgage Investment Trust (PMT) PT Lowered to $10 by UBS on Lower MSR Earnings
• Needham Reiterates Buy Rating on Napco Security Technologies, Inc. (NSSC)